In the run-up to the presidential election, pharma finds itself confronting even more uncertainty than usual - and that's for an industry that has spent the recent past under siege on the pricing front. This flagship MM&M report fleshes out how industry built - or failed to build - this uncertainty into 2019-2020 marketing budgets. The proprietary survey of director-level-and-up biopharma and device marketing execs will showcase a wealth of exclusive research and offer insight into marketers’ current thinking via new data on budgets (and their growth/decline), channel usage and challenges/opportunities (such as the intensified influence of payers).

ONLINE HEALTH COMMUNITIES: Much of the chatter around marketing in and around online health communities has focused on the ones that cater to individuals with rare conditions. While those communities feature hyper-engaged members, so too do the ones for more common afflictions like diabetes and obesity. The problem? There are many, many more such communities. We share marketers' tips for navigating among the many sites and connecting with their most influential members.

BEHAVIORAL MARKETING: Two years ago, behavioral marketing was the medical marketing world's favorite buzz phrase - even as the techniques and strategies themselves remained largely hit or miss. By highlighting three behavioral campaigns that connected, we analyze the opportunities missed amid the early hype - and how the industry has refined its behavioral-based messaging.

SXSW 2020 PREVIEW: HEALTH-TECH IN THE DATA ERA: SXSW is set to feature an even greater volume of content surveying the intersection of health and technology than ever before - and, in turn, an even greater number of A-list presenters and panelists. We check in with show veterans and newcomers alike to gauge their expectations for this year's health track.

PHARMA IMPACT PREVIEW: We offer a primer on one of the industry's most up-and-coming showcases for digital marketers.

PRO AD REPORT, FULL YEAR 2019: MM&M publishes exclusive Kantar's exclusive data on 2019 medical journal ad spend. The report will showcase the top-spending drugmakers, pharma brands and therapeutic categories, as well as the journals and digital publishers that reaped the most ad pages.

PARTNER FORUM: Markteing Automation/MarTech

BONUS DISTRIBUTION: Pharma Impact

Ad Space Close: February 7

Materials Deadline: February 11

Contact Doreen.Gates@Haymarketmedia.com to secure your placement today!